Applied Nutrition, a Liverpool-based company, is set to go public with a £500 million IPO on the London Stock Exchange this October.
- Operating in over 80 countries, the company has experienced significant growth over the past year.
- The IPO will involve selling existing shares, targeting both UK institutional and retail investors.
- Applied Nutrition has strategically appointed key figures to its board, bolstering preparations for the listing.
- This move comes amid declining interest in the London Stock Exchange, highlighting its potential significance.
Applied Nutrition, a company headquartered in Liverpool, has unveiled plans for an initial public offering (IPO) valued at £500 million, scheduled for this October on the London Stock Exchange. This decision positions the listing as one of the most noteworthy of the year on the exchange, as confirmed by a recent report from City AM.
The company has witnessed substantial growth in the 12 months leading up to July, with its products now available in more than 80 countries worldwide. This remarkable expansion has bolstered their confidence in pursuing a public listing, particularly given the potential scale of the IPO which distinguishes it from others this year.
The IPO will focus on offering existing shares from current shareholders to the market, inviting participation from UK institutional investors and retail investors through the Retail Book platform. Interestingly, Applied Nutrition aims to ensure a minimum free float of 25 percent post-IPO, which is a strategic decision to enhance market accessibility and investor appeal.
In light of the impending IPO, Applied Nutrition has been proactively enhancing its leadership team. Notably, Andy Bell, the founder of AJ Bell, joined as chair earlier this year in February, while Tony Buffin and Marnie Millard have taken on roles as non-executive directors, bringing with them substantial industry experience.
The backdrop of this announcement is the struggling appeal of the London Stock Exchange, underscored by a decline in new listings. Last year, the exchange saw only 23 new companies join, a stark drop from 2022’s 45, and an even sharper decline from the 119 listings in 2021. Therefore, Applied Nutrition’s listing not only signifies their own growth ambitions but also the potential to rejuvenate interest in London’s financial markets.
Applied Nutrition’s strategic IPO plans underscore a significant growth trajectory amid a challenging climate for the London Stock Exchange.
